Literature DB >> 1540394

Overexpression of pulmonary surfactant apoprotein A mRNA in alveolar type II cells and nonciliated bronchiolar (Clara) epithelial cells in streptozotocin-induced diabetic rats demonstrated by in situ hybridization.

K Sugahara1, K Iyama, K Sano, T Morioka.   

Abstract

Pulmonary surfactant is critical for gas exchange and is composed of both phospholipids and specific surfactant-associated proteins. The most abundant surfactant protein is termed surfactant apoprotein A (SP-A). This protein is thought to be important in the formation of tubular myelin, in absorption of surfactant to the air-liquid interface, in recycling of surfactant in alveolar type II cells, and in the regulation of secretion. We have examined the expression and localization of SP-A mRNA in streptozotocin-induced diabetic rats by in situ hybridization using a specific rat cDNA probe. Diabetes was induced by intraperitoneal injection of 60 mg/kg streptozotocin. After 10 wk, lungs were excised and examined by in situ hybridization and by light and electron microscopy. The ultrastructural examination demonstrated the marked changes of endoplasmic reticulum of alveolar type II cells, as reported previously. Immunohistostaining of SP-A in diabetic lungs was weak in alveolar type II cells. However, by autoradiographs of in situ hybridization, compared with the control lungs, a larger number of silver grains for the SP-A mRNA were shown in alveolar type II cells and also in some bronchiolar epithelial (Clara) cells from the diabetic lungs. Alveolar type II cells having high contents of silver grains were also increased in number. These results were confirmed by measurement of the SP-A content and by Northern blot analysis. The present study demonstrates an overexpression of SP-A mRNA despite the ultrastructural changes in the endoplasmic reticulum of alveolar type II cells in the diabetic lungs, which will provide new information on the regulatory mechanism of SP-A gene expression.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540394     DOI: 10.1165/ajrcmb/6.3.307

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  6 in total

1.  Serum Clara cell protein levels in lung cancer patients: an assessment of preoperative values and postoperative changes.

Authors:  H Nomori; H Horio; R Kobayashi; S Morinaga
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

2.  Co-expression of collagen types II and X mRNAs in newly formed hypertrophic chondrocytes of the embryonic chick vertebral body demonstrated by double-fluorescence in situ hybridization.

Authors:  K Iyama; M Kitaoka; M Monda; Y Ninomiya; M Hayashi
Journal:  Histochem J       Date:  1994-11

3.  Ultrastructural study of nuclear inclusions immunohistochemically positive for surfactant protein A in pulmonary adenocarcinoma with special reference to their morphogenesis.

Authors:  Shu-Hui Lu; Yuji Ohtsuki; Yoshiki Nonami; Shiro Sasaguri; Jiro Fujita; Masashi Uomoto; Fu-Shan Tao; Makoto Kobayashi; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2006-12-21       Impact factor: 2.309

4.  Protein 1 and Clara cell 10-kDa protein distribution in normal and neoplastic tissues with emphasis on the respiratory system.

Authors:  H Nomori; S Morinaga; R Kobayashi; C Torikata
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

5.  Insulin self-association: effects on lung disposition kinetics in the airways of the isolated perfused rat lung (IPRL).

Authors:  Yinuo Pang; Masahiro Sakagami; Peter R Byron
Journal:  Pharm Res       Date:  2007-05-03       Impact factor: 4.200

6.  Fatty diabetic lung: altered alveolar structure and surfactant protein expression.

Authors:  David J Foster; Priya Ravikumar; Dennis J Bellotto; Roger H Unger; Connie C W Hsia
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-01-08       Impact factor: 5.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.